What is the Future of Cell-Based Assays in Cancer Research?
The future of cell-based assays in cancer research is promising, with ongoing advancements aimed at improving their accuracy and relevance. Organoids and patient-derived xenografts (PDXs) are emerging as powerful tools that offer more clinically relevant models. Additionally, the integration of artificial intelligence and machine learning in data analysis holds the potential to uncover new insights and accelerate the development of cancer therapies.
